...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells
【24h】

GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells

机译:GVHD相关的,炎性体介导的过继转移的骨髓来源抑制细胞的功能丧失

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Myeloid-derived suppressor cells (MDSCs) are a naturally occurring immune regulatory population associated with inhibition of ongoing inflammatory responses. In vitro generation of MDSCs from bone marrow has been shown to enhance survival in an acute model of lethal graft-versus-host disease (GVHD). However, donor MDSC infusion only partially ameliorates GVHD lethality. In order to improve the potential therapeutic benefit and ultimately survival outcomes, we set out to investigate the fate of MDSCs after transfer in the setting of acute GVHD (aGVHD). MDSCs transferred to lethally irradiated recipients of allogeneic donor hematopoietic grafts are exposed to an intense inflammatory environment associated with aGVHD, which we now show directly undermines their suppressive capacity. Under a conditioning regimen and GVHD inflammatory settings, MDSCs rapidly lose suppressor function and their potential to inhibit GVHD lethality, which is associated with their induced conversion toward a mature inflammasome-activated state. We find even brief in vitro exposure to inflammasome-activating mediators negates the suppressive potential of cultured murine and human-derived MDSCs. Consistent with a role for the inflammasome, donor MDSCs deficient in the adaptor ASC (apoptosis-associated speck-like protein containing a CARD), which assembles inflammasome complexes, conferred improved survival of mice developing GVHD compared with wild-type donor MDSCs. These data suggest the use of MDSCs as a therapeutic approach for preventing GVHD and other systemic inflammatory conditions will be more effective when combined with approaches limiting in vivo MDSC inflammasome activation, empowering MDSCs to maintain their suppressive potential.
机译:髓样来源的抑制细胞(MDSCs)是与抑制持续的炎症反应相关的天然免疫调节种群。已显示在致死的移植物抗宿主病(GVHD)的急性模型中,从骨髓中体外产生MDSCs可提高存活率。但是,捐赠人MDSC输注只能部分改善GVHD的致死性。为了提高潜在的治疗益处和最终的生存结果,我们着手研究在急性GVHD(aGVHD)情况下转移后MDSC的命运。转移至同种异体供体造血移植物经致死性照射的接受者的MDSCs暴露于与aGVHD相关的强烈炎症环境中,我们现在证明其直接破坏了它们的抑制能力。在调理方案和GVHD炎性环境下,MDSCs迅速丧失抑制功能,并丧失了抑制GVHD致死性的潜力,这与其诱导的向成熟的炎性体激活状态的转化有关。我们发现,即使是短暂的体外暴露于炎性体激活介质,也无法消除培养的鼠类和人源性MDSC的抑制潜力。与炎性体的作用一致,组装有炎性体复合物的衔接子ASC(含有CARD的细胞凋亡相关斑点样蛋白)缺乏的供体MDSC与野生型供体MDSC相比,改善了发展为GVHD的小鼠的存活。这些数据表明,与限制体内MDSC炎性体活化,赋予MDSC维持其抑制潜能的方法相结合时,使用MDSC作为预防GVHD和其他全身性炎症性疾病的治疗方法将更为有效。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号